Portomesenteric

肠系膜
  • 文章类型: Case Reports
    背景:肥胖是一种严重的情况,会导致糖尿病等非传染性疾病,高血压,和其他人。肥胖的患病率在世界范围内增长非常快,所以遵循减肥手术的结果,最有效的肥胖症治疗方法,正在增加。门静脉中心性静脉血栓(PMVT)是一种罕见的,致命性减肥后并发症最常见于袖状胃切除术和Roux-en-Y胃旁路术。
    方法:一名50岁的绝经女性,体重指数(BMI)为38,在一次吻合胃旁路术(OAGB)后10天因急性腹痛入院。她的实验室检查正常,但是在她的腹部CT扫描和静脉造影中,可见亚急性完全性腔内血栓形成,门静脉左分支及其节段分支腔扩张。她的诊断性腹腔镜检查正常,她出院了,没有任何症状和利伐沙班的处方。
    结论:PMVT是减肥手术后非常罕见且为胎儿的并发症之一。在腹腔镜袖状胃切除术和Roux-en-Y胃旁路术中观察到更多,由于PMVT的高死亡率和胃肠道缺血的原因,因此早期诊断至关重要。
    结论:在本案例报告中,我们看到PMVT可能发生在OAGB之后,重要的是要考虑PMVT作为OAGB后的并发症之一,不要错过病例。
    BACKGROUND: Obesity is a serious situation that leads to non-communicable diseases like diabetes, hypertension, and others. The prevalence of obesity is growing very fast worldwide, so follow the results bariatric surgery, the most effective treatment of obesity, is increasing. Portomesentric vein thrombosis (PMVT) is one of the rare, fatal post-bariatric complications seen most commonly in sleeve gastrectomy and Roux-en-Y gastric bypass.
    METHODS: A 50-year-old menopausal female with a body mass index (BMI) of 38 was admitted with acute abdominal pain 10 days after one-anastomosis gastric bypass (OAGB). Her lab tests were normal, but in her abdominal CT scan with IV contrast, subacute complete intraluminal thrombosis with luminal expansion at the left branch of the portal vein and its segmental branches was seen. Her diagnostic laparoscopy was normal, and she was discharged with no symptoms and a prescription for rivaroxaban.
    CONCLUSIONS: PMVT is one of the complications after bariatric surgery that is very uncommon and fetal. It has been seen more in laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass, and early diagnosis of PMVT is essential due to its high mortality rate and cause of gastrointestinal ischemia.
    CONCLUSIONS: In this case report, we saw that PMVT could happen after OAGB, and it is important to consider PMVT as one of the complications after OAGB to not miss the cases.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:急性肠系膜缺血(AMI)是指肠道灌注不足的突然发作,也可能是内脏静脉阻塞所致。肠门静脉系统(PMVS)是蛋白S缺乏症患者血栓形成的不寻常部位,其阻塞是AMI的罕见原因。本报告的目的是说明在采用开放式腹部(OA)方法治疗的大面积小肠梗塞的情况下,一种成功的策略。
    方法:一名64岁女性因急性腹痛就诊于急诊科,直肠出血,腹泻和呕吐。对比增强计算机断层扫描(CECT)显示小肠缺血和所有PMVS分支完全闭塞。采用OA方法进行手术,并立即开始抗凝治疗。进一步检查发现孤立的蛋白S缺乏和萎缩性胃炎病史。出院时开始使用华法林预防血栓,在一年的随访期间没有记录到血栓事件的复发。
    结论:与蛋白S缺乏相关的PMVS血栓形成是一种罕见的疾病,可迅速导致急腹症。CECT是黄金标准,因为它能检测内脏血栓形成及其可能的并发症,比如肠缺血.如果是手术,计划的二次手术是评估肠活力和可能的缺血进展的最佳策略.
    结论:OA管理在肠缺血切除的情况下发挥着重要作用。在不常见部位血栓形成的患者应进一步检查血栓前状态。
    BACKGROUND: Acute mesenteric ischemia (AMI) refers to the sudden onset of intestinal hypoperfusion that can also result from splanchnic venous occlusion. The portomesenteric venous system (PMVS) is an unusual site of thrombosis in patients with protein S deficiency and its obstruction is a rare cause of AMI. Aim of this report is to illustrate a successful strategy in a case of massive small bowel infarction managed with an open abdomen (OA) approach.
    METHODS: A 64 year-old woman presented to the emergency department with acute abdominal pain, rectal bleeding, diarrhea and vomiting. Contrast-enhanced computed tomography (CECT) showed small bowel ischemia and the complete occlusion of all the PMVS branches. Surgery was performed with an OA approach and anticoagulation was immediately begun. Further workup revealed isolated protein S deficiency and history of atrophic gastritis. Thromboprophylaxis with warfarin was started on discharge and no recurrence of thrombotic events was recorded during the one-year follow-up.
    CONCLUSIONS: PMVS thrombosis related to protein S deficiency is a rare condition that can rapidly lead to an acute abdomen. CECT is the gold standard, because it detects splanchnic thrombosis and its possible complications, like bowel ischemia. In case of surgery, a planned second-look operation is the best strategy to assess bowel viability and possible ischemic progression.
    CONCLUSIONS: OA management plays a fundamental role in case of resection for bowel ischemia. Patients with thrombosis at an uncommon site should be further investigated for prothrombotic states.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    BACKGROUND: Portomesenteric vein thrombosis is a rare but documented complication of laparoscopic surgery. This rare complication is currently being encountered more frequently with the increase in the rates of laparoscopic bariatric surgery procedures being performed worldwide.
    METHODS: A retrospective analysis was performed on all bariatric procedures performed in our center between July 2012 & December 2017 to identify cases complicated by portomesenteric venous thrombosis. The cases were compared in terms of operative details, patient presentation, diagnosis, patient risk factors for developing thrombosis, demographics and thrombophilia analysis & subsequent treatment and prognosis.
    RESULTS: A total of 1030 bariatric procedures were performed between July 2012 & December 2017. Portomesenteric venous thrombosis complicated 3 of these cases (0.29%). Two of these cases had underwent a laparoscopic sleeve gastrectomy while the third had underwent a gastric band removal and a conversion to a single anastomosis gastric bypass. Amongst these patients, 2 were female while 1 was male with an average BMI 38.9 kg/m2. Only one of these patients was a smoker while none of them tested positive for thrombophilias. The diagnosis of portomesenteric venous thrombosis was confirmed with a contrast CT of the abdomen as all patients were re-admitted between 4-20 days post operatively after being discharged on postoperative day 2. All three cases were managed with systemic anticoagulants and none underwent invasive procedures or were re-explored surgically. All were subsequently discharged in good condition.
    CONCLUSIONS: Portomesenteric venous thrombosis is an uncommon yet potentially fatal complication of bariatric surgery. A high index of suspicion, early diagnosis and subsequent adequate management is required. Based on this case series and the potential risk of portomesenteric venous thrombosis, we altered our clinical practice to include a 1 week course of low molecular weight heparin to be administered to all patients after discharge.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号